Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Genedrive PLC (GDRG)

Currency in GBP

GDRG Price Commentary

I dont see any future for the shareholders of GDR
retest and March end result day
retest failed , stopped out.
15.8% drop in one day ???????
why do you think they need placing ?thanks
Now do you know why they need placing?:) Because loss making company. They have to pay salaries :)
This follows the Admission today of 6,500,000 Ordinary Shares of 1.5p each further to the Company's announcement on 31 March 2023 including details of a £5m Equity Prepayment Facility.
Going well at the moment.
Hi folks is there a feeling this will go up soon? Bought when it was super high and holding out hope still!! 🙏
Whats peoples thoughts on the future?
The shares at pre-pandemic level, it looks like the company has no future prospects.
you done any research ?
oh dear
I guess back to 5p again.
Placing haaaaa
but it did back to 5 p
what happened to the 5p ?
World shortage in testing, can gdr pull the rabbit out of the hat? 40p To £4? If they do.
well, it's been up as high as £6.00p in the past, so who knows ?
what price can this reach?
was a joke when prices were at 150p, its still a joke sitting at 28.5p. Pharma stocks was last years play. Likes of Iofina (IOFI) is where u wanna be in now!
RNS released & no sales hence the price drop
surprised the prof isn't on here playing down this surge
Indian approvals granted for gdr . India must be really desperate....
nice big gap to fill. put my bid low and fingers crossed
So where is this NCYT bid for gdr then?
Any approvals or sales yet? Or was it just all made up in the first place ? Maybe after the next placing CEO can get a nice lambo soon.
David's fulfilled promises:22/05/20 "The Company aims to record first commercial sales in June" 22/10/20 "The Company is targeting end of the calendar year for completion of preliminary product evaluations with the release of the final CE marked system in Q1 2021". David says, 'Thanks for the £445,000 salary, bonuses and lavish expenses because I have delivered on every promise!". he also adds....."See you at the next placing!"
How can the ceo justify paying himself £445,000 a year they when they only did £400,000 in sales in THE pandemic year
The answer to your question is because he owns few shares in the company and using this climate as an opportnity to milk investors. I also suggest you don't even look at the expense accounts either. Me and my mates Silles and Paul Barnbrook all warned you, so we feel no empathy.What will happen:- The possibilty of failed approvals is a fairly strong possibilty.- You'll all discover the BC deal is tiny, overhyped and genuinely not needed as labs already have their own routines.- The next placing will occur in Summer/Autumn in the region of 5-10 mil GBP at significant discount- The SP may bounce to 100p and give false hope like it did before. Be warned,
sinking faster than titanic
joke company but next placing will cover extravagant salaries and expenses again for another year. We both preached it and we have now been vindicated.
Once again proven correct. They can't sell anything after a year and two global waves. once vaccinations are complete it is game over here The BC deal is nothing but hot air as I said before. This company is bleeding cash thanks to the bod salary and will need a placing soon . facts are facts and ppl don't listen.
So what happened to £600m takeover? Any sales or approvals yet?
Danaher will eventually buy Genedrive, 400-600m .. around £7 per share, I won't be selling any until then.
Any thoughts on when this would be 🤞
What happened ?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.